LifeMD, Inc. LFMD
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 204.49M | 206.22M | 206.95M | 205.22M | 198.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 204.49M | 206.22M | 206.95M | 205.22M | 198.32M |
| Cost of Revenue | 24.64M | 26.20M | 28.41M | 30.77M | 28.38M |
| Gross Profit | 179.84M | 180.03M | 178.54M | 174.44M | 169.94M |
| SG&A Expenses | 179.61M | 175.15M | 166.66M | 166.79M | 165.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 11.10M | 10.93M | 10.13M | 9.79M | 8.99M |
| Total Operating Expenses | 223.61M | 220.57M | 213.54M | 215.56M | 210.69M |
| Operating Income | -19.13M | -14.34M | -6.60M | -10.34M | -12.37M |
| Income Before Tax | -20.42M | -16.34M | -9.11M | -13.50M | -14.66M |
| Income Tax Expenses | 183.00K | 183.00K | 183.00K | 767.10K | 830.50K |
| Earnings from Continuing Operations | -20.60 | -16.52 | -9.30 | -14.26 | -15.49 |
| Earnings from Discontinued Operations | 21.03M | 22.92M | 24.92M | 5.31M | 5.31M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -228.80K | -733.90K | -1.27M | -1.60M | -1.22M |
| Net Income | 201.10K | 5.67M | 14.35M | -10.55M | -11.40M |
| EBIT | -19.13M | -14.34M | -6.60M | -10.34M | -12.37M |
| EBITDA | -17.63M | -12.98M | -5.39M | -3.18M | -5.34M |
| EPS Basic | -0.06 | 0.05 | 0.23 | -0.31 | -0.34 |
| Normalized Basic EPS | -0.26 | -0.22 | -0.14 | -0.13 | -0.15 |
| EPS Diluted | -0.06 | 0.05 | 0.23 | -0.32 | -0.35 |
| Normalized Diluted EPS | -0.26 | -0.22 | -0.14 | -0.13 | -0.15 |
| Average Basic Shares Outstanding | 188.06M | 184.67M | 180.47M | 175.91M | 171.76M |
| Average Diluted Shares Outstanding | 188.06M | 184.67M | 180.47M | 175.91M | 171.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1,544.70% | 54.83% | 21.64% | -29.45% | -27.25% |